Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
37 articles scientifiques publiés — un praticien à la pointe de la recherche
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
131.5 rhumatos / 100 000 hab. — département bien doté
3 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Influence scientifique
8
8 articles ont été cités au moins 8fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
489
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
41
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
7
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Training and validation of a deep learning U-net architecture general model for automated segmentation of inner ear from CT
2024ArticleEuropean Radiology Experimental
JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles.
2014ArticleNucleic Acids Research
The Transcription Factor Encyclopedia.
2012ArticleGenome Biology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CH ANNECY-GENEVOIS SITE ST JULIEN EN G
1 R AMEDEE VIII DE SAVOIE BP 14110, 74164 ST JULIEN EN GENEVOIS CEDE
CH ANNECY-GENEVOIS SITE ANNECY
1 AV DE L'HOPITAL BP 90074, 74370 EPAGNY METZ TESSY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Kidney international · 2025
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
Abstract Background Vaccination has been shown to attenuate the risk of postacute sequelae following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, no prior population-based studies have evaluated if updated bivalent boosters reduce risk of postacute sequelae following Omicron variant infection, versus ancestral vaccines. Methods National databases were utilized to construct a population-based cohort of adult individuals infected during Omicron-predominant transmission. Risk and excess burden (EB) of prespecified multiorgan new-incident diagnoses at 31–365 days post–SARS-CoV-2 infection were compared between individuals who received prior bivalent boosters and those boosted with ancestral messenger RNA (mRNA) vaccines, using competing-risks regression. Results A total of 1 080 348 vaccine-breakthrough infections after an ancestral mRNA booster were contrasted against 9824 vaccine-breakthrough infections following a bivalent mRNA booster. There was an estimated 37.8% (hazard ratio [HR], 0.62 [95 confidence interval {CI}, .53–.73]) decrease in risk and lower overall EB per 1000 (−28.73 [95% CI, −40.47 to −16.99]) of any postacute sequelae, as well as a 39.9% (HR, 0.62 [95% CI, .52–.73]) decrease in risk and lower EB (−22.95 [95% CI, −32.71 to −13.19]) of any postacute neurological sequelae, among individuals who received prior bivalent boosters, versus those boosted with ancestral mRNA vaccines. Specifically, there was reduced risk of thrombotic disorders (HR, 0.54 [95% CI, .29–.99]), episodic neurological disorders (HR, 0.55 [95% CI, .43–.72]), movement disorders (HR, 0.57 [95% CI, .47–.70]), and autoimmune vasculitis (HR, 0.54 [95% CI, .29–.99]) 31–365 days postinfection among those who received prior bivalent boosters, versus those boosted with ancestral mRNA vaccines. Conclusions Boosting with updated bivalent mRNA vaccines was associated with greater attenuation of risk for postacute sequelae following Omicron variant infection, compared with ancestral mRNA boosters.
Annals of the Academy of Medicine, Singapore · 2025
Introduction: Premature ovarian insufficiency (POI) refers to loss of ovarian activity before the age 40 years. POI has significant detrimental effects on health (infertility, cardiovascular diseases, type 2 diabetes, reduced bone density, dementia), well-being and longevity. This is a practical toolkit for healthcare professionals (HCPs) looking after women with POI. Method: A workgroup comprising specialists in gynaecology, reproductive medicine, endocrinology, genetics and family medicine reviewed relevant guidelines and literature on POI to establish recommendations for the diagnosis and management of POI in Singapore. Result: A summary to assist HCPs manage POI was produced, outlining: (1) the aetiology and consequences of POI; (2) making the diagnosis; (3) hormone therapy (HT) prescribing options including for those with additional medical conditions; (4) counselling women with POI about HT; and (5) long-term management of POI. Conclusion: Timely diagnosis and management of POI is vital to prevent long-term adverse consequences, except infertility. Hormone therapy is the mainstay of treatment and there are no alternatives as effective. Contraindications are very few; estrogen-sensitive cancer is the main contraindication and caution in prescribing may be needed with established coexisting cardiovascular disease. Estrogen dosage is higher than when treating normal menopause, and as a result, the patient might require more progestogen for endometrial protection. Minimising cardiovascular risk factors by following a healthy lifestyle is important. POI is a significant public health issue and it is imperative that women have affordable access to appropriate HT. Large-scale research on POI in Asian women is needed.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Ageing research reviews · 2026 · Journal Article
Ha JS, Jo A, Yeo EJ, Kim YW, et al.
Academic medicine : journal of the Association of American Medical Colleges · 2026 · Journal Article
Westervelt M, Cavallaro S, Boedeker P, Robles J, et al.
Journal of Korean medical science · 2026 · Journal Article
Kwak SH, Lee YH, Han JS, Lim JH, et al.
Archives of osteoporosis · 2026 · Journal Article
Lim JH, Chun J, Min GJ, Kim DB, et al.
Journal of rehabilitation medicine · 2026 · Journal Article
Kim O, Lim J, Park GY
Current allergy and asthma reports · 2025 · Journal Article
Shen JZ, Carlsen ED, Carrillo LF, Cintron D, et al.
Singapore medical journal · 2025 · Journal Article
Ng EC, Xu S, Liu XE, Lim JBT, et al.
Journal of orthopaedic surgery and research · 2025 · Journal Article
Park JY, Lim JY, Kim TK, Cho BW, et al.
Clinical and experimental medicine · 2025 · Journal Article
Sung SE, Park WT, Choi JH, Kim YI, et al.
Frontiers in immunology · 2025 · Journal Article
Anusha Amali A, Tay DJW, Seow Y, Loh M, et al.
Annals of the Academy of Medicine, Singapore · 2025 · Journal Article
Sugianto SRS, Webber L, Safdar Husain F, Viardot-Foucault V, et al.
Journal of nephrology · 2025 · Journal Article
Zou G, Lim J, Rosenberg AZ
International journal of stem cells · 2025 · Journal Article
Jung SI, Choi SH, Kim JW, Lim J, et al.
Hand clinics · 2025 · Journal Article
Lim JX, Chung KC
Gynecologic oncology · 2026 · Journal Article
Musa FB, Boyle TAC, Lim JT, Moore J, et al.
Cancer · 2025 · Journal Article
Duska LR, Lim J, Calderón Boyle TA, Guinter M, et al.
Oncology and therapy · 2025 · Journal Article
Chase DM, Hanna M, Lim JT, Boyle TAC, et al.
The journal of spinal cord medicine · 2026 · Journal Article
Kim HJ, Lim JS, Kim O
GeroScience · 2025 · Journal Article
Do KY, Won CW, Kim M, Lim JY
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025 · Journal Article
Wee LE, Lim JT, Goel M, Malek MIA, et al.
The lancet. Diabetes & endocrinology · 2026 · Journal Article
Wilmot EG, Moore P, Sathyapalan T, Choudhary P, et al.
Cancer · 2025 · Journal Article
Duska LR, Lim J, Calderón Boyle TA, Guinter M, et al.
Clinical obesity · 2025 · Journal Article
Lim JZM, Williams A, Burgess J, O'Connell J, et al.
Current allergy and asthma reports · 2026 · Journal Article
Lim J, Doss J, Shen J, Hershfield M, et al.
Hepatology communications · 2025 · Journal Article
Sollenberger CH, Chang HR, Lim J, Shaik MR, et al.
Journal of cutaneous medicine and surgery · 2025 · Letter
Bai JQA, Geng RSQ, Ding M, Lim JS, et al.
Kidney international · 2025 · Journal Article
Ghang B, Park J, Lee JS, Lim JS, et al.
Journal of community genetics · 2025 · Journal Article
Ng WL, Kee BP, Hussein N, Ng CJ, et al.
Hepatology communications · 2025 · Journal Article
Sollenberger CH, Chang HR, Lim J, Shaik MR, et al.
Journal of cutaneous medicine and surgery · 2025 · Letter
Bai JQA, Geng RSQ, Ding M, Lim JS, et al.
Current allergy and asthma reports · 2026 · Journal Article
Lim J, Doss J, Shen J, Hershfield M, et al.
Rheumatology (Oxford, England) · 2026 · Journal Article
Quick V, Sah S, Dubey S, Mercer L, et al.
Journal of ISAKOS : joint disorders & orthopaedic sports medicine · 2025 · Case Reports
Radhakrishnan R, Lim JTE, Padki A, Toh RX, et al.
Value in health regional issues · 2026 · Journal Article
Ouyang Y, Lim J, Tan B, Lim WY, et al.
Global spine journal · 2026 · Journal Article
Lim JTE, Zeng GJ, Goh GS, Liow MHL, et al.
Retinal cases & brief reports · 2025 · Journal Article
Smith MJ, Lim JI, Chau FY, Lobo-Chan AM
Rheumatology (Oxford, England) · 2026 · Journal Article
Quick V, Sah S, Dubey S, Mercer L, et al.
Clinical nephrology · 2026 · Journal Article
Kim JS, Kim JT, Lim HI, Kim HJ, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Lim JP, Ahmadian M, Du H, Rickert C, et al.
Journal of cutaneous medicine and surgery · 2025 · Letter
Bai JQA, Geng RSQ, Ding M, Lim JS, et al.
Foot & ankle orthopaedics · 2026 · Journal Article
Tan YCJ, Lim J, Radhakrishnan R, Li Z, et al.
Cureus · 2026 · Case Reports
Ghias AF, Black M, Lim J
Immunolocalization of protein domain family PF04427 members
<b>Copyright information:</b>Taken from "NovelFam3000 – Uncharacterized human protein domains conserved across model organisms"BMC Genomics 2006;7():48-48.Published online 13 Mar 2006PMCID:PMC1440326.Copyright © 2006 Kem
Immunolocalization of protein domain family PF03114 members
<b>Copyright information:</b>Taken from "NovelFam3000 – Uncharacterized human protein domains conserved across model organisms"BMC Genomics 2006;7():48-48.Published online 13 Mar 2006PMCID:PMC1440326.Copyright © 2006 Kem
Example query: search by transcription factor
<b>Copyright information:</b>Taken from "PAZAR: a framework for collection and dissemination of cis-regulatory sequence annotation"http://genomebiology.com/2007/8/10/R207Genome Biology 2007;8(10):R207-R207.Published onli
Diverse localization patterns observed by immunolocalization of FLAG-tagged recombinant proteins detected with FLAG-specific antibodies
<b>Copyright information:</b>Taken from "NovelFam3000 – Uncharacterized human protein domains conserved across model organisms"BMC Genomics 2006;7():48-48.Published online 13 Mar 2006PMCID:PMC1440326.Copyright © 2006 Kem
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Full copyright for enhanced digital features is owned by the authors. <strong>Article full text</strong> <br> The full text of this article can be found <b>here</b>. <br> <br> <strong>Provide enhanced digital features fo
Newton: A Language for Describing Physics
This article introduces Newton, a specification language for notating the analytic form, units of measure, and sensor signal properties for physical-object-specific invariants and general physical laws. We designed Newto
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2025 · Journal Article
Backes FJ, Calderón Boyle TA, Lim J, Hartman J, et al.